Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 14 Aug 2026 for Supernus Pharmaceuticals, INC.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Jonathan Rubin: trading record in brief
Jonathan Rubin appears in our data through filings on Supernus Pharmaceuticals, Inc. shares, published by SEC (Form 4). The record holds 13 filings, for trades running from 16 February 2023 to 12 August 2026.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 14 August 2026, the filings show an option exercise in Supernus Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Jonathan Rubin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations13 total
750 shares0Common StockSEC:0001836067-26-000010:0
363 shares@ US$46.570.0006% mcap60.0% of flowCommon StockSEC:0001836067-26-000010:1
1,250 shares0Common StockSEC:0001836067-26-000006:0
1,125 shares0Common StockSEC:0001836067-26-000004:0
1,875 shares0Common StockSEC:0001836067-25-000006:0
314 shares@ US$33.05100.0% of flowCommon StockSEC:0001628280-25-010437:0
1,875 shares0Common StockSEC:0001628280-25-007532:0
750 shares0Common StockSEC:0001628280-24-052575:0
1,250 shares0Common StockSEC:0001104659-24-028272:0
750 shares0Common StockSEC:0001104659-24-027581:0
600 shares0Common StockSEC:0001104659-23-129243:0
750 shares0Common StockSEC:0001104659-23-025366:0
1,500 shares0Common StockSEC:0001104659-23-023832:0
13 of 13 declarations
